Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: AbbVie Adds Neuroscience Heft With Syndesi Acquisition

01 Mar 2022

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Content

AbbVie Buys In On Morphic’s Oral Integrin Inhibitors, To Tune Of $100m

18 Oct 2018

From Iran To The US: From Scientist To Entrepreneur

24 May 2021

Allergan Exits <em>Noctiva</em> Partnership With Serenity Just As FDA Approves Controversial Drug

07 Mar 2017

Kabi Brings In Reddy’s Rituximab As Biosimilar Breakeven Date Retreats

23 Feb 2022

ANI Partners With Oakrum For First US Generic Of Cystadane

16 Feb 2022

Ipsen To Exit Consumer Health And Focus On Specialty Pharma

11 Feb 2022

Pfizer Shopping For Deals That Will Add $25bn To 2030 Revenues

09 Feb 2022

Biocon’s $3.3bn Biosimilars Big Leap Also Marks Viatris’ 'Smart' Exit, Albeit Toehold

28 Feb 2022

Biohaven Returns To Well With Bristol License, Acquires Channel Biosciences

25 Feb 2022

Deal-Making Attitudes Begin To Shift As Funding Options Decline

24 Feb 2022

High-Flying Biotech Valuations Are Falling – And Maybe That’s A Good Thing

24 Feb 2022

Big Pharma Deal Hunters Target RNA Approaches In Race To Build Best Platforms

21 Feb 2022

Intellia Broadens Its Oncology Bets With CRISPR-Edited NK Cell Therapies

16 Feb 2022

J&J Jumps On RNA-Based Small Molecules Train In Pact With Remix

17 Feb 2022

Curve Inks Mammoth Deal With MSD Just Three Years After $6.1m Seed Funding

17 Feb 2022

Collegium, BioDelivery To Combine Pain Portfolios In Proposed Merger

14 Feb 2022

UCB Spinout Syndesi Brings New Approach To Dementia

15 Apr 2018

Deal Watch: BridgeBio To Launch New Subsidiary Around Rare Disease Candidate Obtained From Alexion

18 Jun 2018

ImmunoGen banks $20M up front in Lilly antibody-drug conjugate deal

21 Dec 2011

Ovid Shifts Focus After Angelman Syndrome Drug Disappoints In Phase III

02 Dec 2020

Yselty For Uterine Fibroids Edges Closer To Being Obseva’s First Commercial Product

06 Jul 2020

Related Companies

AbbVie Inc.

Syndesi Therapeutics SA

UCB S.A.

BioNTech SE

Medigene AG

Blueprint Medicines Corporation

Roivant Sciences Ltd.

Acerus Pharmaceuticals Corporation

Serenity Pharmaceuticals LLC

Eli Lilly and Company

ImmunoGen, Inc.

Grifols, S.A.

Equillium, Inc.

Bioniz Therapeutics, Inc.

Roche Holding AG

Aquinnah Pharmaceuticals, Inc.

ObsEva SA

Theramex SPA

Healx

Ovid Therapeutics, Inc.

Merck & Co., Inc.

H. Lundbeck A/S

Serotiny

Tessera Therapeutics

Grupo Ferrer Internacional, S.A.

United Therapeutics Corporation

Morphic Therapeutic, Inc.

Cyclerion Therapeutics, Inc.

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.